Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. [electronic resource]
Producer: 20050411Description: 1456-62 p. digitalISSN:- 1524-4539
- Adrenergic beta-Antagonists -- therapeutic use
- Aged
- Aged, 80 and over
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Antihypertensive Agents -- therapeutic use
- Atenolol -- therapeutic use
- Blood Pressure -- drug effects
- Double-Blind Method
- Female
- Follow-Up Studies
- Heart Rate -- drug effects
- Heart Ventricles -- diagnostic imaging
- Humans
- Hypertension -- complications
- Hypertrophy, Left Ventricular -- diagnostic imaging
- Losartan -- therapeutic use
- Male
- Middle Aged
- Organ Size
- Prospective Studies
- Treatment Outcome
- Ultrasonography
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.